Literature DB >> 29064971

Practice Bulletin No. 185: Pelvic Organ Prolapse.

.   

Abstract

Pelvic organ prolapse (POP) is a common, benign condition in women. For many women it can cause vaginal bulge and pressure, voiding dysfunction, defecatory dysfunction, and sexual dysfunction, which may adversely affect qual-ity of life. Women in the United States have a 13% lifetime risk of undergoing surgery for POP (1). Although POP can occur in younger women, the peak incidence of POP symptoms is in women aged 70-79 years (2). Given the aging population in the United States, it is anticipated that by 2050 the number of women experiencing POP will increase by approximately 50% (3). The purpose of this joint document of the American College of Obstetricians and Gynecologists and the American Urogynecologic Society is to review information on the current understanding of POP in women and to outline guidelines for diagnosis and management that are consistent with the best available scientific evidence.

Entities:  

Mesh:

Year:  2017        PMID: 29064971     DOI: 10.1097/AOG.0000000000002399

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial.

Authors:  J Eric Jelovsek; Matthew D Barber; Linda Brubaker; Peggy Norton; Marie Gantz; Holly E Richter; Alison Weidner; Shawn Menefee; Joseph Schaffer; Norma Pugh; Susan Meikle
Journal:  JAMA       Date:  2018-04-17       Impact factor: 56.272

2.  Documenting pessary offer prior to hysterectomy for management of pelvic organ prolapse.

Authors:  Anne G Sammarco; Daniel M Morgan; Neil S Kamdar; Carolyn W Swenson
Journal:  Int Urogynecol J       Date:  2018-06-22       Impact factor: 2.894

3.  Responsiveness and minimally important difference of SF-6D and EQ-5D utility scores for the treatment of pelvic organ prolapse.

Authors:  Heidi S Harvie; Amanda A Honeycutt; Simon J Neuwahl; Matthew D Barber; Holly E Richter; Anthony G Visco; Vivian W Sung; Jonathan P Shepherd; Rebecca G Rogers; Sharon Jakus-Waldman; Donna Mazloomdoost
Journal:  Am J Obstet Gynecol       Date:  2018-11-22       Impact factor: 10.693

4.  Validation of the Pelvic Organ Prolapse Simple Screening Inventory (POPSSI) in a population of Ethiopian women.

Authors:  Dawit Worku Kassa; Yirgu Gebrehiwot Ferede; Polina Advolodkina
Journal:  BMC Womens Health       Date:  2019-04-03       Impact factor: 2.809

5.  Laser Vaginal Tightening Complications: Report of Three Cases.

Authors:  Ahmed Al-Badr; Waleed H Alkhamis
Journal:  Lasers Surg Med       Date:  2019-06-18       Impact factor: 4.025

6.  Cost-Effectiveness of perioperative Vaginally Administered estrogen in postmenopausal women undergoing prolapse surgery (EVA trial): study protocol for a multicenter double-blind randomized placebo-controlled trial.

Authors:  Eva V Vodegel; Sandra E Zwolsman; Astrid Vollebregt; Ruben G Duijnhoven; Judith E Bosmans; Leonie Speksnijder; Eveline J Roos; Wilbert Spaans; Franca Gerards; Albert Adriaanse; Flora Vernooij; Alfredo L Milani; Marko Sikkema; Mirjam Weemhoff; Marieke Mous; Anne Damoiseaux; Heleen van Dongen; Marinus V/D Ploeg; Joggem Veen; Geerte van de Pol; Bart Broekman; Pieternel Steures; Fernando Tjin-Asjoe; Jolande van der Stege; Ronald Mouw; Carl H van der Vaart; Jan-Paul W R Roovers
Journal:  BMC Womens Health       Date:  2021-12-31       Impact factor: 2.809

7.  Anatomical and functional outcomes after hysterectomy and bilateral sacrospinous ligament fixation for stage IV uterovaginal prolapse: a prospective case series.

Authors:  Tilemachos Kavvadias; Birgitt Schoenfisch; Sara Yvonne Brucker; Christl Reisenauer
Journal:  BMC Urol       Date:  2020-08-19       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.